Posted in | News | Energy

IMI Unveils First HIPPS for Hydrogen Post-Production Processes

IMI has unveiled what is believed to be one of the first high integrity pressure protection system (HIPPS) to protect against overpressure propagation during the hydrogen post-production process.

IMI high integrity pressure protection system. Image Credit: IMI

The new HIPPS is specifically engineered to isolate the source of dangerous high pressure, instead of relieving the excess flow in the case of an overpressure event. This offers a critical layer of protection for pipelines and downstream components and promotes the safe storage of hydrogen post-production, prior to its transportation to the point of use.

As a result, hydrogen producers will be able to increase both safety and availability compared to traditional pressure safety relief valves while avoiding the loss of containment. This will facilitate an increased yield from a comparable time frame versus plants that do not deploy a HIPPS.

The system uses electronic transmitters specifically designed for hydrogen applications and an electronic logic solver to sense a potential overpressure event. If triggered, failsafe valves will be activated within two seconds to isolate the exposure and protect the downstream assets and plant personnel. 

With a long-standing heritage of manufacturing HIPPS for the process industry, the hydrogen HIPPS solution complements IMI’s growing suite of technology to support the entire hydrogen value chain.

This includes its IMI VIVO PEM electrolyser, which was launched in 2023. Available in 100kW to 5MW power class skids, the IMI VIVO electrolyser can be made fully bespoke to end-user requirements thanks to a ‘turnkey’ configuration that includes a high or low-pressure storage tank, compressor and optional fuelling equipment.

IMI also provides a range of critical service valves for hydrogen applications, including ball valves and butterfly valves.

Andrea Pusceddu, Business Development Director for Hydrogen at IMI, said: “Hydrogen has huge potential to support with reducing CO2 emissions in hard-to-abate sectors such as heavy industry and long-distance transport. With the International Energy Agency predicting these applications could account for one-third of global hydrogen demand by 2030, guaranteeing the safety of both the production team and plant equipment will be one of most important priorities for all stakeholders.

“With long-standing expertise in delivering HIPPS systems for a range of severe service applications throughout the process industry, combined with a rapidly developing suite of solutions for the hydrogen value chain, we have been able to call upon our knowledge of both disciplines to create what we believe to be the first HIPPS for hydrogen. Not only will this help our customers’ facilities become safer, but it can also help to increase uptime while increasing revenue potential.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    IMI plc. (2024, May 28). IMI Unveils First HIPPS for Hydrogen Post-Production Processes. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=63071.

  • MLA

    IMI plc. "IMI Unveils First HIPPS for Hydrogen Post-Production Processes". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=63071>.

  • Chicago

    IMI plc. "IMI Unveils First HIPPS for Hydrogen Post-Production Processes". AZoM. https://www.azom.com/news.aspx?newsID=63071. (accessed November 21, 2024).

  • Harvard

    IMI plc. 2024. IMI Unveils First HIPPS for Hydrogen Post-Production Processes. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=63071.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.